EGFR and non-small cell lung carcinoma: Thus, the aims of this study were to evaluate the antiproliferative and antimigratory effects of NCX4040 and NCX4016 in NSCLC cells, investigate their interactions with the EGFR inhibitor, erlotinib, and explore the relationship among NO• release, prostaglandin E2 (PGE2) synthesis inhibition, and the effects of these NO-aspirins.